Seeing Is Believing
Currently out of the existing stock ratings of Robert Burns, 431 are a BUY (88.14%), 58 are a HOLD (11.86%).
Analyst Robert Burns, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 27.52% that have a potential upside of 40.68% achieved within 113 days.
Robert Burns’s has documented 1,010 price targets and ratings displayed on 49 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EXEL, Exelixis at 12-Feb-2026.
Analyst best performing recommendations are on COGT (COGENT BIOSCIENCES).
The best stock recommendation documented was for COGT (COGENT BIOSCIENCES) at 11/4/2025. The price target of $21 was fulfilled within 6 days with a profit of $6.87 (48.62%) receiving and performance score of 81.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 27-Aug-2024
$1.75
$-0.27 (-13.37%)
$5
1 years 5 months 27 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold Since 15-Dec-2023
1 years 6 months 2 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Hold Since 21-Aug-2024
$1.5
$-0.52 (-25.74%)
1 years 6 months 2 days ago
(21-Aug-2024)
0/2 (0%)
$-0.05 (-3.23%)
Buy Since 18-Apr-2018
3 years 10 months 12 days ago
(11-Apr-2022)
0/1 (0%)
$93 (163.16%)
Buy Since 30-Aug-2021
3 years 10 months 12 days ago
(11-Apr-2022)
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Robert Burns is most bullish on?
Which stock is Robert Burns is most reserved on?
What Year was the first public recommendation made by Robert Burns?